Company Overview and News

Perseus Mining's (PMNXF) CEO Jeff Quartermaine on Q3 2018 Results - Earnings Call Transcript

2018-04-16 seekingalpha
Thank you very much. And welcome to this conference call, everybody, to talk about the quarterly report for March 2018. For the information of participants, I'm currently on my way back to Australia from West Africa where I've been for the last couple of weeks since the operations.

Asante Gold - Corporate Update

2018-04-16 globenewswire

Perseus Mining Limited: Activity Report for March 2018 Quarter

2018-04-15 globenewswire
PERTH, Australia, April 15, 2018 (GLOBE NEWSWIRE) -- Perseus Mining Limited (“Perseus” or the “Company”) (TSX:PRU) (ASX:PRU) reports on its activities for the three month period ended March 31, 2018 (the “Quarter”). An executive summary is provided below. However, full details of activities in the March Quarter, including reconciled production and all-in site cash costs, are included in the Company’s March 2018 Quarterly Activity Report released to the market on April 16, 2018.

Perseus Mining Limited: March 2018 Quarterly Activity Report Conference Call

2018-04-09 globenewswire
PERTH, Western Australia, April 09, 2018 (GLOBE NEWSWIRE) -- Perseus Mining Limited (ASX:PRU) (TSX:PRU) is hosting a conference call to discuss the March 2018 Quarterly Report, which is anticipated for release around 8.30am AEDT on Monday April 16, 2018.

Big four banks help ASX climb amid easing trade war concerns

The Australian markets enjoyed a second day of growth with major banks making gains while the big mining companies fell.

Big four banks help ASX climb amid easing trade war concerns

The Australian markets enjoyed a second day of growth with major banks making gains while the big mining companies fell.

Perseus Declares Commercial Production at Sissingué Gold Mine

2018-04-03 globenewswire
PERTH, Western Australia, April 02, 2018 (GLOBE NEWSWIRE) -- Perseus Mining Limited (ASX:PRU) (TSX:PRU) is pleased to advise that:

Perseus achieves commercial gold production at West African operation

Perseus Mining has reached commercial production at the Sissingué gold mine in Côte d’Ivoire, West Africa.

Ivory Coast's Ouattara replaces mines minister

2018-03-01 reuters
ABIDJAN, March 1 (Reuters) - Ivory Coast President Alassane Ouattara replaced the industry and mines minister on Thursday, naming Trade Minister Souleymane Diarrassouba to fill the position on an interim basis.

Perseus Mining's (PMNXF) CEO Jeffrey Quartermaine on Q2 2018 Results - Earnings Call Transcript

2018-01-31 seekingalpha
Well thank you very much and welcome to this conference call to run through Perseus Mining's December 2017 Quarterly Report. For this is information, I'm calling this morning from our Edikan mine here in Ghana.

Gold miners steady on quarterly results

Shares in gold miners Perseus Mining, Ramelius Resources and Evolution Mining have remained steady today following the release of the companies quarterly reports.

Perseus pours first gold at second West African mine

West African-focused miner Perseus Mining has poured first gold at the Sissingué mine in Côte d’Ivoire one month ahead of schedule.

Perseus prepares to launch second gold mine this month

Perseus Mining expects to deliver first gold at its Sissingué operation in Côte d’Ivoire, West Africa this month.

Top 20 Gold Mining Stocks For 2018

2018-01-02 seekingalpha
Above are my Top 20 gold mining stocks for 2018. All of these companies have large resources and are highly undervalued based on their cash flow potential at higher gold prices. They are on this list primarily because of their upside potential. These are either producers or development stocks, although there is one optionality play (Goldmining Inc).

Perseus shares positive estimate for Côte d’Ivoire gold project

Australian gold company Perseus Mining has released initial mineral resource and ore reserve estimates for its Yaouré gold project in Côte d’Ivoire, West Africa.

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...